Literature DB >> 311742

Stimulation of alkaline secretion in amphibian-isolated gastric mucosa by 16,16-dimethyl PGE2 and PGF2 alpha. A proposed explanation for some of the cytoprotective actions of prostaglandins.

A Garner, J R Heylings.   

Abstract

The mechanism of the gastric cytoprotective action of prostaglandins is unknown but seems to be unrelated to inhibition of acid secretion. In the present study, effects of the prostaglandins, 16,16-dimethyl E2 and F2 alpha on H+ and HCO-3 secretion and electrical properties in amphibian-isolated gastric mucosa were studied. Spontaneous net secretion in fundic mucosa from Rana temporaria and Necturus was acid, whereas Necturus antrum secreted only HCO-3. The histamine H2-receptor antagonist, metiamide (10(-3) M), was used to inhibit acid secretion for studies on fundic alkalinization. Nutrient side administration of 16,16-dimethyl E2 (10(-6) M) for 60 min inhibited H+ secretion and stimulated HCO-3 secretion in Rana temporaria fundus. The drug (10(-5) M) also stimulated antral alkalinization. There was a dose-related increase in HCO-3 secretion in Necturus fundus after administration of F2 alpha (10(-5)-10(-4) M), but this drug had no significant effect on H+ secretion. Inhibition of acid secretion by 16,16-dimethyl E2 was associated with an increase in potential difference (PD), but there was no change in electrical resistance. Neither of the prostaglandins affected PD or resistance in alkaline-secreting tissues. Previous work has suggested that gastric HCO-3 secretion has a physiologic role in protecting the mucosal surface. The ability of prostaglandins to stimulate alkaline secretion may contribute to the cytoprotective action of these drugs in the stomach.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 311742

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  31 in total

1.  Pentagastrin gastroprotection against acid is related to H2 receptor activation but not acid secretion.

Authors:  S Tanaka; Y Akiba; J D Kaunitz
Journal:  Gut       Date:  1998-09       Impact factor: 23.059

2.  Effects of misoprostol on gastric acid and mucus secretion in man.

Authors:  D E Wilson; E Quadros; T Rajapaksa; A Adams; M Noar
Journal:  Dig Dis Sci       Date:  1986-02       Impact factor: 3.199

Review 3.  Newer antisecretory agents for peptic ulcer.

Authors:  K W Somerville; M J Langman
Journal:  Drugs       Date:  1983-03       Impact factor: 9.546

4.  Relationship between hydrogen ion concentration and flow of gastric juice during inhibition of gastric secretion in the cat.

Authors:  B H Hirst; L A Labib; J D Reed; J G Stephen
Journal:  J Physiol       Date:  1980-09       Impact factor: 5.182

Review 5.  Recent advances in the treatment of duodenal ulcer disease. A surgical perspective.

Authors:  M W Mulholland; H T Debas
Journal:  West J Med       Date:  1987-09

6.  Role of endogenous gastric mucosal prostaglandins in the formation of acute gastric mucosal lesions induced by aspirin, ethanol, HCl and CH3COOH.

Authors:  I Amioka; T Arima; H Nagashima
Journal:  Gastroenterol Jpn       Date:  1987-06

7.  Role of prostaglandin E2 on human gastric ulcers.

Authors:  K Kobayashi; T Arakawa; H Nakamura; S Chono; H Yamada; T Kamata; T Ono
Journal:  Gastroenterol Jpn       Date:  1982

8.  Effects of non-steroidal anti-inflammatory drugs and prostaglandins on alkali secretion by rabbit gastric fundus in vitro.

Authors:  W D Rees; L C Gibbons; L A Turnberg
Journal:  Gut       Date:  1983-09       Impact factor: 23.059

9.  Inhibition of gastric motor activity by 16,16-dimethyl prostaglandin E2. A possible explanation of cytoprotection.

Authors:  K Takeuchi; Y Nobuhara
Journal:  Dig Dis Sci       Date:  1985-12       Impact factor: 3.199

10.  Effects of hemorrhagic shock on alkaline secretion and mucosal tolerance to acid in rat duodenum. A comparative study with indomethacin.

Authors:  K Takeuchi; Y Nobuhara; H Tanaka; H Nishiwaki; S Okabe
Journal:  Dig Dis Sci       Date:  1988-11       Impact factor: 3.199

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.